A citation-based method for searching scientific literature

Lova Sun, Melina E Marmarelis, Corey J Langer. Semin Radiat Oncol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1-S cell cycle transition in radioresistance of perinecrotic tumor cells.
Y Zhu, T Zhao, S Itasaka, L Zeng, C J Yeom, K Hirota, K Suzuki, A Morinibu, K Shinomiya, G Ou,[...]. Oncogene 2013
22
100

Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer.
Roy S Herbst, Timothy L Madden, Hai T Tran, George R Blumenschein, Christina A Meyers, Lee F Seabrooke, Fadlo R Khuri, Vinay K Puduvalli, Victoria Allgood, Herbert A Fritsche,[...]. J Clin Oncol 2002
85
100



Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
Loredana Santo, Ka Tat Siu, Noopur Raje. Semin Oncol 2015
70
100


FV-429 induces apoptosis and inhibits glycolysis by inhibiting Akt-mediated phosphorylation of hexokinase II in MDA-MB-231 cells.
Yuxin Zhou, Na Lu, Chen Qiao, Ting Ni, Zhiyu Li, Boyang Yu, Qinglong Guo, Libin Wei. Mol Carcinog 2016
21
100

Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
Eiji Furuta, Sudha K Pai, Rui Zhan, Sucharita Bandyopadhyay, Misako Watabe, Yin-Yuan Mo, Shigeru Hirota, Sadahiro Hosobe, Taisei Tsukada, Kunio Miura,[...]. Cancer Res 2008
268
100

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
100

Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression.
Maimon E Hubbi, Daniele M Gilkes, Hongxia Hu, Kshitiz, Ishrat Ahmed, Gregg L Semenza. Proc Natl Acad Sci U S A 2014
60
100

Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
Lei Huang, Qilin Ao, Qinghua Zhang, Xiaokui Yang, Hui Xing, Fang Li, Gang Chen, Jianfeng Zhou, Shixuan Wang, Gang Xu,[...]. J Cancer Res Clin Oncol 2010
50
100

Fatty acid synthase as a potential therapeutic target in cancer.
Richard Flavin, Stephane Peluso, Paul L Nguyen, Massimo Loda. Future Oncol 2010
338
100

Taxol (paclitaxel): mechanisms of action.
S B Horwitz. Ann Oncol 1994
239
100

Advances in Small-Cell Lung Cancer (SCLC) Translational Research.
Benjamin J Drapkin, Charles M Rudin. Cold Spring Harb Perspect Med 2021
4
100


Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.
Youyun Yang, Hailan Liu, Zhaomin Li, Zijin Zhao, Michelle Yip-Schneider, Qipeng Fan, C Max Schmidt, E Gabriela Chiorean, Jingwu Xie, Liang Cheng,[...]. Int J Biochem Mol Biol 2011
62
100

Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy.
Jaya Krishnan, Marianne Suter, Renata Windak, Tatiana Krebs, Allison Felley, Christophe Montessuit, Malgorzata Tokarska-Schlattner, Ellen Aasum, Anna Bogdanova, Evelyne Perriard,[...]. Cell Metab 2009
238
100

Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia.
Lionel Flamant, Annick Notte, Noelle Ninane, Martine Raes, Carine Michiels. Mol Cancer 2010
72
100

HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression.
De Huang, Tingting Li, Xinghua Li, Long Zhang, Linchong Sun, Xiaoping He, Xiuying Zhong, Dongya Jia, Libing Song, Gregg L Semenza,[...]. Cell Rep 2014
176
100

Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxol-based Chemotherapy for Stage IV NSCLC.
Tomohiro Tamura, Kunihiko Miyazaki, Toshihiro Shiozawa, Hiroaki Satoh. Clin Lung Cancer 2018
2
100

Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
Zheng Li, Yi Qing, Wei Guan, Mengxia Li, Yu Peng, Shiheng Zhang, Yanli Xiong, Dong Wang. Cancer Chemother Pharmacol 2014
39
100




Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.
Liang-Ting Lin, Chih-Hsien Chang, Hsiang-Lin Yu, Ren-Shyan Liu, Hsin-Ell Wang, Shu-Jun Chiu, Fu-Du Chen, Te-Wei Lee, Yi-Jang Lee. J Nucl Med 2014
20
100

Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer.
Sharanya Sivanand, Matthew G Vander Heiden. Cancer Cell 2020
51
100

Increasing the added-value of onions as a source of antioxidant flavonoids: a critical review.
M R Pérez-Gregorio, J Regueiro, J Simal-Gándara, A S Rodrigues, D P F Almeida. Crit Rev Food Sci Nutr 2014
38
100

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary.
Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag,[...]. Front Oncol 2019
9
100

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Janette Greenhalgh, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Marty Chaplin, John A Green. Cochrane Database Syst Rev 2021
4
100

FV-429 Induced Apoptosis Through ROS-Mediated ERK2 Nuclear Translocation and p53 Activation in Gastric Cancer Cells.
Yuxin Zhou, Libin Wei, Haiwei Zhang, Qinsheng Dai, Zhiyu Li, Boyang Yu, Qinglong Guo, Na Lu. J Cell Biochem 2015
13
100

Metabolomics, metabolic flux analysis and cancer pharmacology.
Lingfan Liang, Fei Sun, Hongbo Wang, Zeping Hu. Pharmacol Ther 2021
1
100

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.
Javier A Menendez, Ruth Lupu. Nat Rev Cancer 2007
100

Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Lin-Xi Shi, Rui Ma, Rong Lu, Qiong Xu, Zhi-Feng Zhu, Li Wang, Chun-Lei Zhou, Xiao-Lei Li, Hua-Li Zhang, Zhi Yao. Cancer Lett 2008
39
100

Src family kinases and paclitaxel sensitivity.
Xiao-Feng Le, Robert C Bast. Cancer Biol Ther 2011
61
100

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
100


Reactive oxygen species-mitochondria pathway involved in FV-429-induced apoptosis in human hepatocellular carcinoma HepG2 cells.
Zhen Yang, Lei Qiang, Tian Wu, Fei-Hong Chen, Hui-Ying Yang, Qing Zhao, Mei-Juan Zou, Ya-Jing Sun, Zhi-Yu Li, Qing-Long Guo. Anticancer Drugs 2011
8
100

Human cancer: is it linked to dysfunctional lipid metabolism?
Sarwar Hashmi, Yi Wang, Devi S Suman, Ranjit S Parhar, Kate Collison, Walter Conca, Futwan Al-Mohanna, Randy Gaugler. Biochim Biophys Acta 2015
25
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.